Stout has advised OpenClinica, a provider of eClinical software solutions and a portfolio company of Thompson Street Capital Partners (TSCP), in the acquisition of BuildClinical, the leading patient recruitment solution for academic researchers.

BuildClinical, founded in 2017 and headquartered in New York City, specializes in accelerating clinical trial patient recruitment through targeted digital advertising, addressing gaps in patient awareness and access. The acquisition enables OpenClinica to offer an integrated end-to-end platform that encompasses recruitment, eligibility, consent, enrollment, and data capture, enhancing its ability to serve academic research centers, CROs, pharmaceutical sponsors, biotech companies, and medical device manufacturers.

OpenClinica provides a secure SaaS platform for automating data acquisition in clinical trials. Trusted by global leaders in life sciences, academia, and government, OpenClinica has powered more than 10,000 studies involving over 5 million patients.